A large cohort of chemotherapy-naïve triple-negative breast cancer (TNBC), clinicopathologic features, deconvoluted RNA immune signatures, and intraepithelial and stromal TIME were identified in subsets of PD-L1+ and PD-L1- TNBC.
[Clinical Cancer Research]
6445218
{6445218:X2QZKX4A}
apa
50
1
163306
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-1f347115ebbf1a06e5722453674332d6%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22X2QZKX4A%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Carter%20et%20al.%22%2C%22parsedDate%22%3A%222021-01-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECarter%2C%20J.%20M.%2C%20Polley%2C%20M.-Y.%20C.%2C%20Leon-Ferre%2C%20R.%20A.%2C%20Sinnwell%2C%20J.%2C%20Thompson%2C%20K.%20J.%2C%20Wang%2C%20X.%2C%20Ma%2C%20Y.%2C%20Zahrieh%2C%20D.%2C%20Kachergus%2C%20J.%20M.%2C%20Solanki%2C%20M.%2C%20Boughey%2C%20J.%20C.%2C%20Liu%2C%20M.%20C.%2C%20Ingle%2C%20J.%20N.%2C%20Kalari%2C%20K.%20R.%2C%20Couch%2C%20F.%20J.%2C%20Thompson%2C%20E.%20A.%2C%20%26amp%3B%20Goetz%2C%20M.%20P.%20%282021%29.%20Characteristics%20and%20spatially-defined%20immune%20%28micro%29landscapes%20of%20early-stage%20PD-L1-positive%20triple-negative%20breast%20cancer.%20%3Ci%3EClinical%20Cancer%20Research%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F1078-0432.CCR-21-0343%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F1078-0432.CCR-21-0343%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DX2QZKX4A%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Characteristics%20and%20spatially-defined%20immune%20%28micro%29landscapes%20of%20early-stage%20PD-L1-positive%20triple-negative%20breast%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jodi%20M.%22%2C%22lastName%22%3A%22Carter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mei-Yin%20C.%22%2C%22lastName%22%3A%22Polley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roberto%20A.%22%2C%22lastName%22%3A%22Leon-Ferre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%22%2C%22lastName%22%3A%22Sinnwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%20J.%22%2C%22lastName%22%3A%22Thompson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xue%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yaohua%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Zahrieh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20M.%22%2C%22lastName%22%3A%22Kachergus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malvika%22%2C%22lastName%22%3A%22Solanki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judy%20C.%22%2C%22lastName%22%3A%22Boughey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minetta%20C.%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20N.%22%2C%22lastName%22%3A%22Ingle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Krishna%20R.%22%2C%22lastName%22%3A%22Kalari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fergus%20J.%22%2C%22lastName%22%3A%22Couch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Aubrey%22%2C%22lastName%22%3A%22Thompson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20P.%22%2C%22lastName%22%3A%22Goetz%22%7D%5D%2C%22abstractNote%22%3A%22Purpose%3A%20PD-%28L%291-targeted%20therapies%20have%20shown%20modest%20survival%20benefit%20in%20triple-negative%20breast%20cancer%20%28TNBC%29.%20PD-L1%2B%20microenvironments%20in%20TNBC%20are%20not%20well-characterized%20and%20may%20inform%20combinatorial%20immune%20therapies.%20Herein%2C%20we%20characterized%20clinicopathologic%20features%2C%20RNA-based%20immune%20signatures%20and%20spatially-defined%20protein-based%20immune%20microenvironments%20%28TIME%29%20in%20early-stage%20PD-L1%2B%20and%20PD-L1-%20TNBC.%20Experimental%20Design%3A%20From%20a%20large%20cohort%20of%20chemotherapy-na%5Cu00efve%20TNBC%2C%20clinicopathologic%20features%2C%20deconvoluted%20RNA%20immune%20signatures%2C%20and%20intraepithelial%20and%20stromal%20TIME%20%28Nanostring%20GeoMXTM%29%20were%20identified%20in%20subsets%20of%20PD-L1%2B%20and%20PD-L1-%20TNBC%2C%20as%20defined%20by%20FDA-approved%20PD-L1%20companion%20assays.%20Results%3A%20228%5C%2F499%20%2846%25%29%20TNBC%20were%20PD-L1%2B%20%28SP142%3A%20%7Bgreater%20than%20or%20equal%20to%7D1%25%20immune%20cells-positive%29.%20Using%20PD-L1%2022C3%2C%2046%25%20had%20combined%20positive%20score%20%28CPS%29%20%7Bgreater%20than%20or%20equal%20to%7D%201%20and%2016%25%20had%20CPS%20%7Bgreater%20than%20or%20equal%20to%7D10.%20PD-L1%2B%20TNBC%20were%20higher%20grade%20with%20higher%20TILs%20%28p%20%3C0.05%29.%20PD-L1%20was%20not%20associated%20with%20improved%20survival%20following%20adjustment%20for%20TILs%20and%20other%20variables.%20RNA%20profiles%20of%20PD-L1%2B%20TNBC%20had%20increased%20dendritic%20cell%2C%20macrophages%20and%20T%5C%2FB%20cell%20subset%20features%3B%20and%20decreased%20myeloid-derived%20suppressor%20cells.%20PD-L1%2B%20stromal%20and%20intraepithelial%20TIME%20were%20highly%20enriched%20in%20IDO-1%2C%20HLA-DR%2C%20CD40%20and%20CD163%20compared%20to%20PD-L1-%20TIME%2C%20with%20spatially-specific%20alterations%20in%20CTLA-4%2C%20STING%2C%20and%20fibronectin.%20Macrophage%20and%20antigen%20presentation-related%20proteins%20correlated%20most%20strongly%20with%20PD-L1%20protein.%20Conclusions%3A%20In%20this%20early-stage%20TNBC%20cohort%2C%20nearly%2050%25%20were%20PD-L1%2B%20%28SP142%20companion%20assay%29%20while%2016%25%20were%20PD-L1%2B%20with%20the%2022C3%20companion%20assay.%20PD-L1%2B%20TNBC%20had%20specific%20myeloid-derived%20and%20lymphoid%20features.%20Spatially-defined%20PD-L1%2BTIME%20were%20enriched%20in%20several%20clinically-actionable%20immune%20proteins.%20These%20data%20may%20inform%20future%20studies%20on%20combinatorial%20immunotherapies%20for%20patients%20with%20PD-L1%2B%20TNBC.%22%2C%22date%22%3A%222021%5C%2F01%5C%2F01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1158%5C%2F1078-0432.CCR-21-0343%22%2C%22ISSN%22%3A%221078-0432%2C%201557-3265%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fclincancerres.aacrjournals.org%5C%2Fcontent%5C%2Fearly%5C%2F2021%5C%2F06%5C%2F08%5C%2F1078-0432.CCR-21-0343%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-06-10T19%3A05%3A43Z%22%7D%7D%5D%7D
Carter, J. M., Polley, M.-Y. C., Leon-Ferre, R. A., Sinnwell, J., Thompson, K. J., Wang, X., Ma, Y., Zahrieh, D., Kachergus, J. M., Solanki, M., Boughey, J. C., Liu, M. C., Ingle, J. N., Kalari, K. R., Couch, F. J., Thompson, E. A., & Goetz, M. P. (2021). Characteristics and spatially-defined immune (micro)landscapes of early-stage PD-L1-positive triple-negative breast cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.CCR-21-0343 Cite
